Dashboard
Healthy long term growth as Operating profit has grown by an annual rate 31.77%
With a growth in Net Profit of 29.29%, the company declared Outstanding results in Sep 26
Stock is technically in a Mildly Bearish range
With ROCE of 6.5, it has a Very Attractive valuation with a 0.5 Enterprise value to Capital Employed
Majority shareholders : Promoters
Below par performance in long term as well as near term
Stock DNA
Trading & Distributors
INR 216 Cr (Micro Cap)
8.00
19
1.82%
0.08
4.84%
0.41
Total Returns (Price + Dividend) 
Latest dividend: 0.988201644619235 per share ex-dividend date: Sep-10-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Sicagen India Ltd is Rated Hold by MarketsMOJO
Sicagen India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Sicagen India Ltd Reports Outstanding Quarterly Performance Amid Shifting Financial Trends
Sicagen India Ltd has delivered an outstanding financial performance in the quarter ended September 2026, marking a significant improvement in key metrics such as revenue, profitability, and operational efficiency. This shift from a previously very positive trend to an outstanding one highlights the company’s strengthening fundamentals amid a challenging market environment.
Read More
Sicagen India Ltd is Rated Hold by MarketsMOJO
Sicagen India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 September 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 31 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More Announcements 
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
19-Nov-2026 | Source : BSENotice of Postal Ballot dated 02.11.2026 seeking shareholders approval for alteration of Articles of Association of the Company.
Un-Audited Financial Results For The Quarter & Half Year Ended 30.09.2026.
02-Nov-2026 | Source : BSEUn-audited Financial (Standalone & Consolidated) Results of the Company for the Quarter & Half Year ended 30th September 2026.
Board Meeting Outcome for Outcome Of The Board Meeting Dated 02.11.2026
02-Nov-2026 | Source : BSEOutcome of the Board Meeting dated 02nd November 2026.
Corporate Actions 
No Upcoming Board Meetings
Sicagen India Ltd has declared 10% dividend, ex-date: 10 Sep 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 3 Schemes (0.0%)
Held by 3 FIIs (2.47%)
Ranford Investments Ltd. (18.7%)
Mercantile Ventures Limited (2.5%)
27.44%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 14.68% vs 2.90% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 29.29% vs 55.38% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 0.31% vs 24.09% in Sep 2024
Growth in half year ended Sep 2025 is -2.91% vs 75.29% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 8.70% vs 11.44% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 3.58% vs 77.09% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 9.21% vs 12.06% in Mar 2025
YoY Growth in year ended Mar 2026 is 5.61% vs 62.64% in Mar 2025